首页> 美国卫生研究院文献>Journal of Young Pharmacists : JYP >Formulation Development and Evaluation of Alginate Microspheres of Ibuprofen
【2h】

Formulation Development and Evaluation of Alginate Microspheres of Ibuprofen

机译:布洛芬藻酸盐微球的配方开发与评价

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The present study was designed to investigate the effects of different variables on the release profile of ibuprofen microspheres formulated using modified emulsification method. Eight batches of microspheres (F1-F8) were prepared by applying 23 factorial design. The amount of sodium alginate, amount of calcium chloride, and amount of magnesium stearate were selected as formulation variables. All the batches were evaluated in terms of percentage yield, percentage encapsulation efficiency and in vitro release characteristics. The batch F7 was found to be optimum batch and was further characterized via scanning electron microscopy (SEM) and particle size analysis. Multiple linear regression was applied to confirm significant effect of each variable on release characteristics. The model developed in the present study can be effectively utilized to achieve the formulation with desired release characteristics.
机译:本研究旨在调查不同变量对使用改良乳化法配制的布洛芬微球释放曲线的影响。应用2 3 因子设计制备了八批微球(F1-F8)。选择藻酸钠的量,氯化钙的量和硬脂酸镁的量作为配方变量。根据百分产率,百分包封效率和体外释放特性评估所有批次。发现批次F7是最佳批次,并且通过扫描电子显微镜(SEM)和粒度分析进一步表征。应用多元线性回归来确认每个变量对释放特性的显着影响。在本研究中开发的模型可以有效地用于实现具有所需释放特性的制剂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号